POLISCOPE
Back to feed
Part ofFda →

The civic record

Read. Follow. Verify.

Congressional Hearing on FDA Medical Device User Fee Program

Original title: EXAMINING FDA'S MEDICAL DEVICE USER FEE PROGRAM

Record date · January 1, 2018

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House Subcommittee on Health held a hearing on March 28, 2017, to review the FDA's Medical Device . The session featured testimony from FDA officials, medical device industry representatives, and patient advocacy groups regarding the program's performance and future reauthorization.

Why it matters

This hearing serves as the legislative oversight process for the Medical Device User Fee Amendments (), which determine how the FDA funds the review and approval process for new medical devices, directly impacting the speed at which new medical technologies reach the market.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Medical Device Manufacturers

These companies pay user fees to the FDA and are subject to the agency's review timelines for product approval.

Directly affected

FDA

The agency receives and manages user fee funding to support its regulatory review operations.

Directly affected

Patients

Patients rely on the FDA's review process to ensure the safety and efficacy of medical devices before they enter the market.

Key Facts

  • The hearing was held on March 28, 2017, by the House Subcommittee on Health.
  • The primary subject was the examination of the FDA's Medical Device User Fee Program.
  • Witnesses included representatives from the FDA, the Alliance for Aging Research, CVRx, Cohera Medical, and GE Healthcare.
  • The hearing record includes prepared statements from all witnesses and committee members.
Show all 5 facts
  • Dr. Jeffrey Shuren, Cynthia A. Bens, and Patrick Daly did not provide answers to submitted questions for the record by the time of printing.

Frequently Asked Questions

What is the Medical Device User Fee Program?
It is a program where medical device companies pay fees to the FDA to help fund the agency's review process for new medical device applications.
Why was this hearing held?
To conduct oversight of the FDA's performance and to gather information for the reauthorization of the .

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

cross reference100% confidence

Unanswered Questions

The document explicitly notes that several key witnesses failed to provide answers to submitted questions for the record by the time of printing.

Connected Entities

Patrick Daly, Diane Wurzburger, Robert Kieval and 4 more
PersonPatrick Daly“President and CEO, Cohera Medical”Map →
PersonDiane Wurzburger“Executive of Regulatory Affairs, GE Healthcare”Map →
PersonRobert Kieval“Founder and CEO, CVRx”Map →
PersonCynthia A. Bens“Vice President of Public Policy, Alliance for Aging Research”Map →
OrganizationFood and Drug Administration“Federal agency responsible for medical device regulation”Map →
PersonMichael C Burgess“Chairman of the Subcommittee on Health”Map →
PersonJeffrey Shuren“Director, Center for Devices and Radiological Health, FDA”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record